[1]陈国兰,黄秋菊,李玉兰.2型糖尿病周围神经病变与血清促甲状腺激素关系的研究[J].医学信息,2019,32(06):86-88.[doi:10.3969/j.issn.1006-1959.2019.06.027]
　CHEN Guo-lan,HUANG Qiu-ju,LI Yu-lan.Study on the Relationship between Type 2 Diabetic Peripheral Neuropathy and Serum Thyroid Stimulating Hormone[J].Journal of Medical Information,2019,32(06):86-88.[doi:10.3969/j.issn.1006-1959.2019.06.027]
点击复制

2型糖尿病周围神经病变与血清促甲状腺激素关系的研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年06期
页码:
86-88
栏目:
论著
出版日期:
2019-03-15

文章信息/Info

Title:
Study on the Relationship between Type 2 Diabetic Peripheral Neuropathy and Serum Thyroid Stimulating Hormone
文章编号:
1006-1959（2019）06-0086-03
作者:
陈国兰; 黄秋菊; 李玉兰
（柳州市人民医院内分泌科，广西 柳州 545006）
Author(s):
CHEN Guo-lan; HUANG Qiu-ju; LI Yu-lan
(Department of Endocrinology,Liuzhou People's Hospital,Liuzhou 545006,Guangxi,China)
关键词:
2型糖尿病; 糖尿病周围神经病变; 促甲状腺激素
Keywords:
Type 2 diabetes; Diabetic peripheral neuropathy; Thyroid stimulating hormone
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2019.06.027
文献标志码:
A
摘要:
目的 分析2型糖尿病（T2DM）患者周围神经病变与血清促甲状腺激素（TSH）水平的关系。方法 选择329例柳州市人民医院内分泌科住院T2DM患者进行横断面研究，按照有无神经病变分为糖尿病周围神经病变（DPN）组193例和无糖尿病周围神经病变（NDPN）组136例。收集所有患者临床资料，检测两组患者HbAlc、TC、TG、HDL-C、LDL-C、TSH水平。结果 两组HbAlc、TC、HDL-C、LDL-C、TSH组间比较，差异无统计学意义（P＞0.05）；DPN组年龄大于NDPN组，糖尿病病程长于NDPN组，统计学意义显著（P＜0.01）；DPN组TG水平低于NDPN组，差异有统计学意义（P＜0.05）。Logistic回归分析发现，HbA1c、病程及年龄进入最终回归方程[OR=1.170，95%CI：1.048~1.305（HbA1c）；OR=1.059，95%CI：1.013~1.108（病程）；OR=1.043，95%CI：1.015~1.072（年龄）]，HbA1c、病程及年龄是DPN发生的危险因素。结论 HbA1c、病程及年龄是DPN发生的危险因素，住院T2DM患者DPN与血清TSH水平无明显相关。
Abstract:
Objective To analyze the relationship between peripheral neuropathy and serum thyroid stimulating hormone (TSH) levels in patients with type 2 diabetes mellitus (T2DM). Methods A total of 329 patients with T2DM in the Department of Endocrinology, Liuzhou People's Hospital were selected for cross-sectional study. According to the presence or absence of neuropathy, 193 patients with diabetic peripheral neuropathy (DPN) and 136 patients without diabetic peripheral neuropathy (NDPN). The clinical data of all patients were collected and the levels of HbAlc, TC, TG, HDL-C, LDL-C and TSH were detected in the two groups. Results There was no significant difference between the two groups of HbAlc, TC, HDL-C, LDL-C and TSH (P>0.05);The age of DPN group was longer than that of NDPN group. The duration of diabetes was longer than that of NDPN group,the statistical significance was significant (P<0.01); the TG level in the DPN group was lower than that in the NDPN group,the difference was statistically significant (P<0.05). Logistic regression analysis found that HbA1c, disease duration and age entered the final regression equation [OR=1.170, 95%CI: 1.048~1.305 (HbA1c); OR=1.059, 95%CI: 1.013~1.108 (sick course); OR=1.043, 95 %CI: 1.015~1.072 (age)], HbA1c, duration of disease and age are risk factors for DPN. Conclusion HbA1c, duration of disease and age are risk factors for the development of DPN. There is no significant correlation between DPN and serum TSH levels in hospitalized T2DM patients.

参考文献/References:

[1]Qiao X,Zheng H,Zhang S,et al.C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study[J].Diabetol Metab Syndr,2017,11(1):12. [2]Ozair M,Noor S,Raghav A,et al.Prevalence of thyroid disorders in North Indian Type 2 diabetic subjects: A cross sectional study[J].Diabetes Metab Syndr,2018,12(3):301-304. [3]Centeno MM,Gómez RL,Fregenal M,et al.Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus[J].Medicina (B Aires),2016,76(6):355-358. [4]Palma CC,Pavesi M,Nogueira VG,et al.Prevalence of thyroid dysfunction in patients with diabetes mellitus[J].Diabetol Metab Syndr,2013,5(1):58. [5]Qiu GZ,Tian W,Fu HT,et al.Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction[J].Biochem Biophys Res Commun,2016,471(1):135-141. [6]Krásnik V,Stefanicková J,Fabková J,et al.Prevalence of the Diabetic Retinopathy and Genetic Factors Significance in the Development of Diabetic Retinopathy in Patients with Diabetes Mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study[J].Cesk Slov Oftalmol,2015,71(5):237-242. [7]Gupta R,Misra A.Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities[J].J Diabetes,2016,8(4):470-482. [8]Wong CK,Wong WC,Wan EY,et al.Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP)[J].Endocrine,2016,53(2):412-422. [9]Gao CX,Yang B,Guo Q,et al.High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism[J].Horm Metab Res,2015,47(3):220-224. [10]Rodríguez AJ,Nunes VS,Mastronardi CA,et al.Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies[J].J Diabetes Complications,2016,30(2):357-367. [11]齐琪,张秋梅,李春君,等.亚临床甲状腺功能减退症与2型糖尿病患者糖尿病视网膜病变相关性研究[J].中华眼底病杂志,2017,33(3):235-239. [12]Luo YY,Zhao J,Han XY,et al.Relationship Between Serum Zinc Level and Microvascular Complications in Patients with Type 2 Diabetes[J].Chin Med J (Engl),2015,128(24):3276-3282. [13]Takkar N,Takkar JP,Patil N,et al.Association between Subclinical Hypothyroidism and Severe Diabetic Retinopathy in Type 2 Diabetic Patients[J].Research Journal of Pharmaceutical,Biological and Chemical Sciences,2016,7(3):314-318. [14]Zhao W,Zeng H,Zhang X,et al.A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients[J].Diabetes Res Clin Pract,2016,115(1):122-129. [15]宋宜宁.亚临床甲减与2型糖尿病微血管并发症相关性的临床分析[D].蚌埠医学院,2016.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(06):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(06):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(06):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]龚玉萍.中药足浴联合硫辛酸治疗糖尿病周围神经病变临床分析[J].医学信息,2018,31(05):18.[doi:10.3969/j.issn.1006-1959.2018.05.006]
　GONG Yu-ping.Clinical Analysis of Traditional Chinese Medicine Foot Bath Combined with Lipoic Acid in the Treatment of Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(06):18.[doi:10.3969/j.issn.1006-1959.2018.05.006]
[5]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(06):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[6]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(06):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[7]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(06):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[8]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(06):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[9]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(06):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[10]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(06):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[11]赖璐华,李玉兰,黄秋菊,等.有营养风险的2型糖尿病周围神经病变患者的临床特征研究[J].医学信息,2022,35(17):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]
　LAI Lu-hua,LI Yu-lan,HUANG Qiu-ju,et al.Clinical Characteristics of Type 2 Diabetic Peripheral Neuropathy Patients with Nutritional Risk[J].Journal of Medical Information,2022,35(06):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]
[12]施 洋,向蔚婷,毛玉琴,等.2型糖尿病患者微血管并发症危险因素相关性分析[J].医学信息,2025,38(02):92.[doi:10.3969/j.issn.1006-1959.2025.02.016]
　SHI Yang,XIANG Weiting,MAO Yuqin,et al.Correlation Analysis of Risk Factors of Microvascular Complications in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2025,38(06):92.[doi:10.3969/j.issn.1006-1959.2025.02.016]
[13]李智慧,曹春丽,吴淑琼,等.2型糖尿病周围神经病变的危险因素分析[J].医学信息,2026,39(01):127.[doi:10.3969/j.issn.1006-1959.2026.01.023]
　LI Zhihui,CAO Chunli,WU Shuqiong,et al.Analysis of Risk Factors for Type 2 Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2026,39(06):127.[doi:10.3969/j.issn.1006-1959.2026.01.023]

更新日期/Last Update: 2019-03-15